DENTSPLY SIRONA (NASDAQ:XRAY) Receives Sell (D-) Rating from Weiss Ratings

Key Points

• DENTSPLY SIRONA received a "sell (D-)" rating from Weiss Ratings, indicating potential concerns about its stock performance.
• Recent analyses show a decreasing target price from multiple firms, with Wells Fargo revising it from $16.00 to $15.00, and Evercore ISI from $17.00 to $13.00.
• DENTSPLY SIRONA had a quarterly earnings report that surpassed expectations, posting $0.52 EPS against an estimated $0.50, despite a year-over-year revenue decline of 4.9%.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report)'s stock had its "sell (d-)" rating restated by equities researchers at Weiss Ratings in a research report issued to clients and investors on Friday,Weiss Ratings reports.

Other analysts have also recently issued research reports about the company. Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, August 8th. Barrington Research decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, August 8th. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Saturday, October 18th. Evercore ISI decreased their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating on the stock in a report on Wednesday, October 8th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $18.00.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock traded down $0.05 during mid-day trading on Friday, hitting $13.11. 2,150,365 shares of the company were exchanged, compared to its average volume of 3,030,537. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The business has a fifty day moving average of $13.36 and a 200 day moving average of $14.49. DENTSPLY SIRONA has a 1-year low of $11.69 and a 1-year high of $24.86. The company has a market capitalization of $2.62 billion, a PE ratio of -2.77, a price-to-earnings-growth ratio of 0.82 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same period in the prior year, the company posted $0.49 earnings per share. The business's revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, sell-side analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $25,000. Trust Co. of Toledo NA OH acquired a new position in DENTSPLY SIRONA in the second quarter valued at about $27,000. Parkside Financial Bank & Trust lifted its stake in DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,477 shares during the period. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $26,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $26,000. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.